VTAK

Price Chart

Key Financial Metrics

Key Facts

• Existing investors agreed to purchase 2,050 shares of Series C-4 Convertible Preferred Stock at $1,000 stated value per share for aggregate gross proceeds of $2.05 million.
• The Series C-4 shares are convertible into common stock at $1.00 per share, yielding up to 2,050,000 common shares.
• Conversion price on all outstanding Series C-1, C-2, C-3, C-4, Series D, and Series J convertible preferred stock was reduced from $2.30 to $1.00 per share.
• The conversion price reduction applies to both existing and newly issued Series C-4 shares.
• Shares issued upon conversion of the Series C-4 Preferred Stock are restricted securities with no registration for resale; additional shares from Series J conversion price reduction are also unregistered.
• The company effected a 1-for-10 reverse stock split on October 5, 2026, just days before this filing.

Financial Impact

Immediate $2.05M gross proceeds; potential dilution of up to 2,050,000 common shares from the new Series C-4 issuance plus additional dilution from the broad conversion price reduction on all outstanding convertible preferred series. The conversion price cut from $2.30 to $1.00 per share dramatically increases the number of common shares issuable upon conversion of existing preferred stock.

Risk Factors

• Massive potential dilution from conversion of all outstanding preferred shares at the new $1.00 conversion price, far below the prior $2.30 floor.
• Restricted stock status may limit immediate selling but creates overhang once Rule 144 eligibility is met.
• Recurring reliance on convertible preferred financing indicates ongoing cash burn and difficulty accessing traditional capital markets.
• Reverse stock split followed by dilutive conversion suggests the common stock price may face significant downward pressure.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

US Market Status